ARROWHEAD PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Arrowhead Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -66.5 %, a 171% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Assets for 2024 was -66.5 %, a 171% decline from 2023.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Assets for 2023 was -24.6 %, a 2.89% increase from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Assets for 2022 was -25.3 %, a 21.2% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -66.5 -42 -171% Jul 1, 2024 Sep 30, 2024
Q2 2024 -66.7 -44.5 -201% Apr 1, 2024 Jun 30, 2024
Q1 2024 -59.9 -41.3 -222% Jan 1, 2024 Mar 31, 2024
Q4 2023 -38.6 -18.2 -89.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -24.6 +0.73 +2.89% Jul 1, 2023 Sep 30, 2023
Q2 2023 -22.2 -0.19 -0.87% Apr 1, 2023 Jun 30, 2023
Q1 2023 -18.6 -2.58 -16.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -20.3 +5.43 +21.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -25.3 -4.42 -21.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -22 -1.92 -9.58% Apr 1, 2022 Jun 30, 2022
Q1 2022 -16.1 +2.73 +14.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -25.8 -6.58 -34.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -20.9 -5.67 -37.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -20 -15.3 -321% Apr 1, 2021 Jun 30, 2021
Q1 2021 -18.8 -20.9 -1004% Jan 1, 2021 Mar 31, 2021
Q4 2020 -19.2 -32.4 -245% Oct 1, 2020 Dec 31, 2020
Q3 2020 -15.2 -35.2 -176% Jul 1, 2020 Sep 30, 2020
Q2 2020 -4.75 -21 -129% Apr 1, 2020 Jun 30, 2020
Q1 2020 2.08 -2.18 -51.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 13.3 +30.1 Oct 1, 2019 Dec 31, 2019
Q3 2019 20 +69.5 Jul 1, 2019 Sep 30, 2019
Q2 2019 16.2 +66.6 Apr 1, 2019 Jun 30, 2019
Q1 2019 4.25 +45.1 Jan 1, 2019 Mar 31, 2019
Q4 2018 -16.9 +15.8 +48.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -49.5 -21.5 -76.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -50.4 -14.7 -41.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -40.8 +8.48 +17.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -32.7 +33.2 +50.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -28.1 +49.8 +64% Jul 1, 2017 Sep 30, 2017
Q2 2017 -35.7 +43.9 +55.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -49.3 +17.5 +26.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -65.9 -1.57 -2.44% Oct 1, 2016 Dec 31, 2016
Q3 2016 -77.9 -16.8 -27.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 -79.5 -24.6 -44.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -66.8 -18.3 -37.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -64.3 -26.4 -69.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -61.1 -26.3 -75.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -54.9 -17.2 -45.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 -48.5 -1.07 -2.26% Jan 1, 2015 Mar 31, 2015
Q4 2014 -37.9 +42.9 +53.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -34.8 +82.3 +70.3% Jul 1, 2014 Sep 30, 2014
Q2 2014 -37.7 +68.6 +64.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -47.4 +115 +70.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -80.8 +55.3 +40.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 -117 -6.05 -5.45% Jul 1, 2013 Sep 30, 2013
Q2 2013 -106 -7.84 -7.96% Apr 1, 2013 Jun 30, 2013
Q1 2013 -163 -94 -137% Jan 1, 2013 Mar 31, 2013
Q4 2012 -136 Oct 1, 2012 Dec 31, 2012
Q3 2012 -111 Jul 1, 2012 Sep 30, 2012
Q2 2012 -98.5 Apr 1, 2012 Jun 30, 2012
Q1 2012 -68.7 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.